arrow
D

Dario Giuffrida

istituto oncologico del mediterraneo
H指数:39
被引数:6,208

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review

年轻成年及成年发病癌症幸存者的晚期内分泌-代谢并发症:全面评估与管理策略。意大利医学肿瘤学会(AIOM)、意大利医学糖尿病学会(AMD)、意大利糖尿病学会(SID)、意大利内分泌学会(SIE)、意大利药理学学会(SIF)多学科批判性综述

2025-12-030
OAAI
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET)

非功能性晚期GEP-NENs的管理临床实践指南:意大利医学肿瘤学会(AIOM)与意大利神经内分泌肿瘤学会(ITANET)合作,采用GRADE方法进行证据评估和推荐。

2025-11-120
OAAI
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies

实体肿瘤和糖尿病患者疫苗接种:现有证据与建议。一份来自多学科科学学会专家组的立场声明

2025-04-230
OA
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view
2024-06-276
OAAI
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
2024-05-010
OAAI
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
2024-01-043
OAAI
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper

癌症患者的糖尿病管理。意大利医学肿瘤学协会,意大利医学糖尿病学家协会,意大利糖尿病学会,意大利内分泌学会和意大利药理学学会多学科共识立场文件

2023-12-017
OAAI
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial

评估卡博替尼联合兰瑞肽在胃肠胰腺和胸部神经内分泌肿瘤中的安全性和活性: II期LOLA试验的原理和方案

2023-09-266
OAAI
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view

MiRNA失调是2型糖尿病和癌症发展的共同途径的基础: 意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利糖尿病学会 (SID)/意大利内分泌学会 (SIE)/意大利药理学会 (SIF) 多学科批判性观点

2023-06-0114
OAAI
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
2023-04-177
OAAI
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells
2023-03-1112
OAAI
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

肿瘤学中的皮质类固醇: 使用,过度使用,适应症,禁忌症。意大利医学肿瘤学协会 (AIOM)/意大利医学糖尿病学家协会 (AMD)/意大利内分泌学会 (SIE)/意大利药理学学会 (SIF) 多学科共识立场文件

2022-12-0114
OAAI